热门资讯> 正文
十四行诗宣布首席执行官Pankaj Mohan去世
2025-04-01 19:47
- Immunotherapeutic drugs developer Sonnet BioTherapeutics Holdings (NASDAQ:SONN) announced on Tuesday the passing of founder and CEO Pankaj Mohan.
- Board Member Raghu Rao has been appointed interim CEO.
- Chief Business Officer Stephen McAndrew has been promoted to the post of President and Chief Business Officer
More on Sonnet BioTherapeutics
- Seeking Alpha’s Quant Rating on Sonnet BioTherapeutics
- Historical earnings data for Sonnet BioTherapeutics
- Financial information for Sonnet BioTherapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
